StockNews.com initiated coverage on shares of Theravance Biopharma (NASDAQ:TBPH – Get Rating) in a research note released on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised their price target on shares of Theravance Biopharma from $19.00 to $20.00 in a research note on Tuesday, May 9th. Theravance […]
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) SVP Richard A. Graham sold 2,322 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $11.26, for a total value of $26,145.72. Following the completion of the sale, the senior vice president now directly […]
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) dropped 5% during trading on Wednesday . The company traded as low as $10.55 and last traded at $10.55. Approximately 98,089 shares changed hands during trading, a decline of 80% from the average daily volume of 498,166 shares. The stock had previously closed at $11.11. Analyst Upgrades and […]
Theravance Biopharma (NASDAQ:TBPH – Get Rating) had its price objective lifted by HC Wainwright from $19.00 to $20.00 in a research report sent to investors on Tuesday morning, The Fly reports. HC Wainwright also issued estimates for Theravance Biopharma’s Q2 2023 earnings at ($0.27) EPS, Q3 2023 earnings at ($0.17) EPS, Q4 2023 earnings at […]
Theravance Biopharma (NASDAQ:TBPH – Get Rating) had its price objective boosted by HC Wainwright from $19.00 to $20.00 in a report published on Tuesday, The Fly reports. Separately, StockNews.com began coverage on Theravance Biopharma in a report on Thursday, March 16th. They set a hold rating for the company. Theravance Biopharma Stock Performance Shares of […]